October 12, 2017
Anavex shows data from certain Alzheimer’s disease drug trial
Anavex Life Sciences has reported pharmacokinetic (PK) and pharmacodynamic (PD) data for ANAVEX2-73 from its positive Phase 2a study in…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Alzheimer’s
July 21, 2017
Alzheimer’s drugs market to grow in next 5 years
The global Alzheimer’s drugs market to grow at a CAGR of 1.90% during the period 2017-2021, according to ResearchandMarkets, with Key vendors being Allergan, Eisai Pharmaceuticals, Johnson & Johnson, and Novartis, with other other prominent vendors Amgen and Pfizer.
February 8, 2017
Lundbeck gives up on Alzheimer’s drug, rival to Axovant pill
Two remaining late-stage clinical trials testing an experimental Alzheimer’s drug from Denmark’s Lundbeck have failed, scuppering hopes for the medicine and underscoring the difficulty of developing such treatments.
December 13, 2016
Pharnext: New approach in the treatment of Alzheimer’s disease
A French biopharmaceutical company focused on neurodegenerative diseases Pharnext, said that testing of a Pleodrug being developed for the treatment of…
December 9, 2016
Alzheimer’s disease drug study disappoints Lilly
Eli Lilly has presented detailed results of its disappointing phase 3 Expedition3 trial at the 9th Clinical Trials on Alzheimer’s…
September 12, 2016
Karuna and PureTech comparing KarXI to xanomeline (Alzheimer’s and Schizophrenia)
The study, which will be conducted in up to 70 healthy individuals, aims to evaluate the tolerability of KarXT compared to xanomeline alone.
March 15, 2016
Decoding the molecular ties between vascular disease and Alzheimer’s
Scientists have long been interested in how the vascular system — the body’s network of large and small blood vessels — may be involved in the onset and progression of Alzheimer’s disease and related dementias.
December 30, 2015
Anavex reports net loss for fiscal year 2015 $12.1M
Anavex had cash and cash equivalents of $15.3 million as of September 30, 2015, compared with $7.3 million as at…
December 3, 2015
Anavex appoints Preclinical Operations vice president
Anavex has appointed Ulrich Elben, PhD as Vice President of Preclinical Operations, who will be responsible for the pipeline development and optimization.
November 30, 2015
DNA repair factor linked to breast cancer may also play a role in Alzheimer’s disease
Low levels of breast cancer factor 1 (BRCA1) protein in the brain may contribute to dementia, according to results of a National Institutes of Health (NIH)-funded study, published in Nature Communications.